NuCana plc Banner Image

NuCana plc has reached its limit for free report views

Work for NuCana plc? Upgrade Your Profile and unlock all your annual reports.

NuCana plc

  • Ticker NCNA
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
NuCana plc Logo Image
  • 11-50 Employees
  • Based in Edinburgh, Scotland
NuCana is a clinical-stage biopharmaceutical company focused on significantly improving treatment outcomes for cancer patients by applying their ProTide technology to transform some of the most widely prescribed chemotherapy agents, nucleoside analogs, into more effective and safer medicines. While these conventional agents remain part of the standard of care for the treatment of many solidMore and hematological tumors, their efficacy is limited by cancer cell resistance mechanisms and they are often poorly tolerated. Utilizing their proprietary technology, they are developing new medicines, ProTides, designed to overcome key cancer resistance mechanisms and generate much higher concentrations of anti-cancer metabolites in cancer cells. NuCana’s robust pipeline includes three ProTides in clinical development.
NuCana plc

Most Recent Annual Report

NuCana plc MOST RECENT 2019 Annual Report

Report Locked. NuCana plc has reached its limit for free report views.

Older/Archived Annual Reports